Clinical Trials Browser

Phase 2 × Completed × Tadalafil × Clear all

NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

7 enrolled 14 charts

GastrointestinalHead & Neck

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07333976 2026-01-12

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Phase 2 Completed

Peripheral Nervous System Diseases, Neurotoxicity Syndromes

NCT01697800 2020-02-28

A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

Phase 2 Completed

40 enrolled 5 charts

Squamous Cell Carcinoma of Head and Neck

NCT00894413 2019-06-11

A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

Phase 2 Completed

45 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck